Covid Was Mild & Barely Killed Anyone Ventilator-Acquired Pneumonia Killed Millions
This article was originally published by Ethan Huff at Natural News under the title: FACT CHECK: Covid Was Mild and Barely Killed Anyone –
This article was originally published by Ethan Huff at Natural News under the title: FACT CHECK: Covid Was Mild and Barely Killed Anyone –
Getty Images by John V. Williams, University of Pittsburgh In the year 2000, Dutch scientists went on a mission of exploration – not to discover
Welcome back to the “52 in 52” series. This collection of posts features recently published must-know articles. This week the series covers
As of November 2022, the World Bank recorded that close to 70% of Somalia’s population lives in poverty and 90% suffer from multidimensional
Doctors have started to warn the public of a dangerous fungal illness that’s spreading across the United States right now. The fungus seems to be
Hopkinsville, KY – Two organizations are teaming up to raise vaccination rates in the Pennyroyal region. Kentucky Association of Health Plans
Do the benefits outweigh the risks of acid-blocker drugs, also known as proton pump inhibitors like Nexium, Prilosec, and Zantac? What about baking
China’s COVID cases overwhelm hospitals By Martin Quin Pollard BEIJING, Dec 26 (Reuters) – In more than three decades of emergency medicine,
Representational image. News18 On 12 November, World Pneumonia Day is observed to raise awareness about the complications and issues regarding
RSV vaccine race heats up with highly effective GSK shot By Natalie Grover LONDON, Oct 13 (Reuters) – Data unveiled on Thursday showed
Okay, you’re going to think that I’m always sick. And, to be frank, during the past few months, it’s been challenging. However, normally, I am
This article was originally published by Tyler Durden at ZeroHedge. In a press conference dripping with a mix of exasperation and dry-witted
GSK closer to cracking elusive vaccine for common respiratory virus June 10, 2022, 4:40 AM EDT By Natalie Grover LONDON, June 10 (Reuters) – GSK
Friday’s Column: Brent’s Bent Brent Pollard I was chit-chatting with a friend from college about his latest work assignment, which took him to
GSK to spend up to $3.3 bln on Affinivax to boost vaccines roster May 31, 2022, 4:12 AM EDT By Pushkala Aripaka May 31 (Reuters) – GSK (GSK.L) on